Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Prospective follow-up in various subtypes of cardiomyopathies: insights from the ESC EORP Cardiomyopathy Registry

JR. Gimeno, PM. Elliott, L. Tavazzi, M. Tendera, JP. Kaski, C. Laroche, R. Barriales-Villa, P. Seferovic, E. Biagini, E. Arbustini, LR. Lopes, A. Linhart, J. Mogensen, A. Hagege, MA. Espinosa, A. Saad, AP. Maggioni, ALP. Caforio, PH. Charron,...

. 2021 ; 7 (2) : 134-142. [pub] 20210315

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
MR/T005181/1 Medical Research Council - United Kingdom
MR/T024062/1 Medical Research Council - United Kingdom

E-resources Online Full text

NLK ProQuest Central from 2016-10-01 to 1 year ago
Health & Medicine (ProQuest) from 2016-10-01 to 1 year ago

AIMS: The European Society of Cardiology (ESC) European Observational Research Programme (EORP) Cardiomyopathy Registry is a prospective multinational registry of consecutive patients with cardiomyopathies. The objective of this report is to describe the short-term outcomes of adult patients (≥18 years old). METHODS AND RESULTS: Out of 3208 patients recruited, follow-up data at 1 year were obtained in 2713 patients (84.6%) [1420 with hypertrophic (HCM); 1105 dilated (DCM); 128 arrhythmogenic right ventricular (ARVC); and 60 restrictive (RCM) cardiomyopathies]. Improvement of symptoms (dyspnoea, chest pain, and palpitations) was globally observed over time (P < 0.05 for each). Additional invasive procedures were performed: prophylactic implantation of implantable cardioverter-defibrillator (ICD) (5.2%), pacemaker (1.2%), heart transplant (1.1%), ablation for atrial or ventricular arrhythmia (0.5% and 0.1%). Patients with atrial fibrillation increased from 28.7% to 32.2% of the cohort. Ventricular arrhythmias (VF/ventricular tachycardias) in ICD carriers (primary prevention) at 1 year were more frequent in ARVC, then in DCM, HCM, and RCM (10.3%, 8.2%, 7.5%, and 0%, respectively). Major cardiovascular events (MACE) occurred in 29.3% of RCM, 10.5% of DCM, 5.3% of HCM, and 3.9% of ARVC (P < 0.001). MACE were more frequent in index patients compared to relatives (10.8% vs. 4.4%, P < 0.001), more frequent in East Europe centres (13.1%) and least common in South Europe (5.3%) (P < 0.001). Subtype of cardiomyopathy, geographical region, and proband were predictors of MACE on multivariable analysis. CONCLUSIONS: Despite symptomatic improvement, patients with cardiomyopathies remain prone to major clinical events in the short term. Outcomes were different not only according to cardiomyopathy subtypes but also in relatives vs. index patients, and according to European regions.

2nd Department of Medicine Department of Cardiovascular Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Assistance Publique Hôpitaux de Paris Hôpital Européen Georges Pompidou Cardiology Department Sorbonne Paris Cité INSERM U970 Paris France

Centre for Inherited Cardiovascular Diseases Great Ormond Street Hospital Great Ormond Street London WC1N 3JH UK

Department of Cardiology and Structural Heart Diseases School of Medicine in Katowice Medical University of Silesia Ziolowa Street 45 47 40 635 Katowice Poland

Department of Cardiology Odense University Hospital 5000 Odense C Denmark

Department of Cardiology University of Bologna S Orsola Malpighi Hospital Via Giuseppe Massarenti 9 40138 Bologna Italy

Department of Cardiology Zagazig University Hospital Zagazig Egypt

Division of Cardiology Department of Cardiological Thoracic and Vascular Sciences University of Padova via N Giustiniani 2 35100 Padova Italy

EURObservational Research Programme European Society of Cardiology 2035 Route des colles CS 80179 Biot 06903 Sophia Antipolis Cedex France

Fondazione IRCCS Policlinico San Matteo Viale Camillo Golgi 19 27100 Pavia Italy

GVM Care and Research E S Health Science Foundation Maria Cecilia Hospital Via Corriera 1 48010 Cotignola Italy

Heart Failure Center University of Belgrade School of Medicine Belgrade University Medical Center Koste Todorovica 8 11 000 Belgrade Serbia

Inherited Cardiac Disease Unit Complejo Hospitalario Universitario de A Coruña Calle As Xubias 84 15006 A Coruña Spain

Inherited Cardiac Disease Unit Hospital Clínico Universitario Virgen de la Arrixaca Ctra Murcia Cartagena s n El Palmar 30120 Murcia Spain

Inherited Cardiac Disease Unit Hospital General Universitario Gregorio Marañón 28007 Madrid Spain

Serviço de Cardiologia Hospital Garcia de Orta E P E Av Torrado da Silva 2805 267 Almada Portugal

Sorbonne Université Centre de Référence des Maladies Cardiaques Héréditaires Assistance Publique Hôpitaux de Paris ICAN Inserm UMR1166 Hôpital Pitié Salpêtrière Paris France

University College London and Inherited Cardiac Diseases Unit St Bartholomew's Hospital West Smithfield Paul O'Gorman Building 72 Huntley St London WC1E 6AG UK

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004537
003      
CZ-PrNML
005      
20220127145153.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ehjqcco/qcaa075 $2 doi
035    __
$a (PubMed)33035297
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Gimeno, Juan R $u Inherited Cardiac Disease Unit, Hospital Clínico Universitario Virgen de la Arrixaca, Ctra. Murcia-Cartagena s/n. El Palmar, 30120 Murcia, Spain
245    10
$a Prospective follow-up in various subtypes of cardiomyopathies: insights from the ESC EORP Cardiomyopathy Registry / $c JR. Gimeno, PM. Elliott, L. Tavazzi, M. Tendera, JP. Kaski, C. Laroche, R. Barriales-Villa, P. Seferovic, E. Biagini, E. Arbustini, LR. Lopes, A. Linhart, J. Mogensen, A. Hagege, MA. Espinosa, A. Saad, AP. Maggioni, ALP. Caforio, PH. Charron, EORP Cardiomyopathy Registry Investigators group
520    9_
$a AIMS: The European Society of Cardiology (ESC) European Observational Research Programme (EORP) Cardiomyopathy Registry is a prospective multinational registry of consecutive patients with cardiomyopathies. The objective of this report is to describe the short-term outcomes of adult patients (≥18 years old). METHODS AND RESULTS: Out of 3208 patients recruited, follow-up data at 1 year were obtained in 2713 patients (84.6%) [1420 with hypertrophic (HCM); 1105 dilated (DCM); 128 arrhythmogenic right ventricular (ARVC); and 60 restrictive (RCM) cardiomyopathies]. Improvement of symptoms (dyspnoea, chest pain, and palpitations) was globally observed over time (P < 0.05 for each). Additional invasive procedures were performed: prophylactic implantation of implantable cardioverter-defibrillator (ICD) (5.2%), pacemaker (1.2%), heart transplant (1.1%), ablation for atrial or ventricular arrhythmia (0.5% and 0.1%). Patients with atrial fibrillation increased from 28.7% to 32.2% of the cohort. Ventricular arrhythmias (VF/ventricular tachycardias) in ICD carriers (primary prevention) at 1 year were more frequent in ARVC, then in DCM, HCM, and RCM (10.3%, 8.2%, 7.5%, and 0%, respectively). Major cardiovascular events (MACE) occurred in 29.3% of RCM, 10.5% of DCM, 5.3% of HCM, and 3.9% of ARVC (P < 0.001). MACE were more frequent in index patients compared to relatives (10.8% vs. 4.4%, P < 0.001), more frequent in East Europe centres (13.1%) and least common in South Europe (5.3%) (P < 0.001). Subtype of cardiomyopathy, geographical region, and proband were predictors of MACE on multivariable analysis. CONCLUSIONS: Despite symptomatic improvement, patients with cardiomyopathies remain prone to major clinical events in the short term. Outcomes were different not only according to cardiomyopathy subtypes but also in relatives vs. index patients, and according to European regions.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    12
$a fibrilace síní $7 D001281
650    12
$a kardiologie $7 D002309
650    12
$a kardiomyopatie $x epidemiologie $7 D009202
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    _2
$a prospektivní studie $7 D011446
650    _2
$a registrace $7 D012042
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Elliott, Perry M $u University College London and Inherited Cardiac Diseases Unit, St. Bartholomew's Hospital, West Smithfield, Paul O'Gorman Building 72 Huntley St., London WC1E 6AG, UK
700    1_
$a Tavazzi, Luigi $u GVM Care and Research, E.S. Health Science Foundation, Maria Cecilia Hospital, Via Corriera, 1, 48010 Cotignola, Italy
700    1_
$a Tendera, Michal $u Department of Cardiology and Structural Heart Diseases, School of Medicine in Katowice, Medical University of Silesia, Ziolowa Street 45/47, 40-635 Katowice, Poland
700    1_
$a Kaski, Juan P $u Centre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital, Great Ormond Street, London WC1N 3JH, UK
700    1_
$a Laroche, Cecile $u EURObservational Research Programme, European Society of Cardiology, 2035 Route des colles, CS 80179 Biot, 06903 Sophia-Antipolis Cedex, France
700    1_
$a Barriales-Villa, Roberto $u Inherited Cardiac Disease Unit, Complejo Hospitalario Universitario de A Coruña, Calle As Xubias, 84, 15006 A Coruña, Spain
700    1_
$a Seferovic, Petar $u Heart Failure Center, University of Belgrade School of Medicine, Belgrade University Medical Center, Koste Todorovica 8, 11 000, Belgrade, Serbia
700    1_
$a Biagini, Elena $u Department of Cardiology, University of Bologna/S. Orsola-Malpighi Hospital, Via Giuseppe Massarenti, 9, 40138 Bologna, Italy
700    1_
$a Arbustini, Eloisa $u Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi, 19, 27100 Pavia, Italy
700    1_
$a Lopes, Luis R $u Serviço de Cardiologia, Hospital Garcia de Orta. E:P.E. Av. Torrado da Silva, 2805-267 Almada, Portugal
700    1_
$a Linhart, Ales $u Second Department of Medicine - Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Mogensen, Jens $u Department of Cardiology, Odense University Hospital, 5000 Odense C, Denmark
700    1_
$a Hagege, Albert $u Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Cardiology Department, Sorbonne Paris Cité, INSERM U970, Paris, France
700    1_
$a Espinosa, Maria A $u Inherited Cardiac Disease Unit, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain
700    1_
$a Saad, Aly $u Department of Cardiology, Zagazig University Hospital, Zagazig, Egypt
700    1_
$a Maggioni, Aldo P $u GVM Care and Research, E.S. Health Science Foundation, Maria Cecilia Hospital, Via Corriera, 1, 48010 Cotignola, Italy $u EURObservational Research Programme, European Society of Cardiology, 2035 Route des colles, CS 80179 Biot, 06903 Sophia-Antipolis Cedex, France
700    1_
$a Caforio, Alida L P $u Division of Cardiology, Department of Cardiological Thoracic and Vascular Sciences, University of Padova, via N Giustiniani 2, 35100 Padova, Italy
700    1_
$a Charron, Philippe H $u Sorbonne Université, Centre de Référence des Maladies Cardiaques Héréditaires, Assistance Publique-Hôpitaux de Paris, ICAN, Inserm, UMR1166, Hôpital Pitié-Salpêtrière, Paris, France
710    2_
$a EORP Cardiomyopathy Registry Investigators group
773    0_
$w MED00200141 $t European heart journal. Quality of care & clinical outcomes $x 2058-1742 $g Roč. 7, č. 2 (2021), s. 134-142
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33035297 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145149 $b ABA008
999    __
$a ok $b bmc $g 1751863 $s 1155686
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 7 $c 2 $d 134-142 $e 20210315 $i 2058-1742 $m European heart journal. Quality of care & clinical outcomes $n Eur Heart J Qual Care Clin Outcomes $x MED00200141
GRA    __
$a MR/T005181/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a MR/T024062/1 $p Medical Research Council $2 United Kingdom
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...